CGBC Study

Do you live with Migraine?

We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a period of up to five weeks. Individuals will be evaluated to determine their eligibility to participate in this study. Each person who qualifies will receive the study drug and study-related medical exams at no cost, as well as compensation for time and travel.

This study is researching an FDA-approved treatment currently available for migraine prevention.

Inclusion Criteria:

Have a diagnosis of migraine, with or without aura
Have a frequency of less than 15 monthly headache days
Participants can be on no more than 1 other migraine preventive treatment


Exclusion Criteria:

Participants with a history of GI problems
Participants with type 1 or type 2 diabetes
BMI <40 kg/m2
Participants with cardiac pacemakers or other implanted or portable electromechanical device
Participants currently on mAb CGRP antagonists

If you would like more information or to find out if you are eligible to participate please contact Rebecca Hogan at 716-558-5670.

Call Us (716) 250-2000